Skip to main content
letter
. 2020 Jun 5;10(2):e53. doi: 10.1002/ctm2.53

FIGURE 2.

FIGURE 2

Clinicopathologic‐genomic nomogram to predict the survival of patients undergoing atezolizumab. A, Receiver operating characteristic curves correlating the nomogram with 3‐year overall survival of atezolizumab‐treated patients. B, Decision curve analysis comparing the clinically predictive usefulness between the nomogram and the bTMB